Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters

被引:30
|
作者
Chace, Donald H. [1 ]
Lim, Timothy [2 ]
Hansen, Christina R. [1 ]
De Jesus, Victor R. [2 ]
Hannon, W. Harry [2 ]
机构
[1] Pediatrix Med Grp Inc, Pediatrix Analyt, Ctr Res & Educ, Sunrise, FL 33323 USA
[2] Ctr Dis Control & Prevent, Newborn Screening Qual Assurance Program, Atlanta, GA 30341 USA
关键词
Tandem mass spectrometry; Succinylacetone; Acylcarnitines; Tyrosinemia type 1; Dried blood spots; Newborn screening; TANDEM MASS-SPECTROMETRY; TYROSINEMIA TYPE-I; HEPATORENAL TYROSINEMIA; HEREDITARY TYROSINEMIA; SPECIMENS; URINE; QUANTIFICATION; INFANTS;
D O I
10.1016/j.cca.2009.06.017
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The utilization of succinylacetone (SUAC) as the primary metabolic marker for tyrosinemia Type 1 is now well known. thus new methods have been developed to analyze SUAC as a first tier test in newborn screening. One approach is to prepare a SUAC hydrazine derivative from the dried blood spots (DBS) previously utilized in the extraction of acylcarnitine (AC) and amino acids (AA). The final derivatized products of SUAC, AA and AC are combined in a single tandem mass spectrometric (MS/MS) analysis. However, butyl esterification techniques may result in contamination of underivatized acylcarnitines by as much as 20%. We have developed a simple wash step to improve the combined analysis of SUAC, AA and AC in DBS by MS/MS. Methods: AA and AC were extracted with methanol containing labeled internal standard from 3.2 mm punches taken from the DBS specimen. The previously extracted blood spot that remains after removal of the methanol extraction solvent was used in the preparation of SUAC with and without additional washing of the blood spot. The butyl ester eluates of AA and AC, and SUAC hydrazine derivatives were recombined and measured by MS/MS. Results: Three additional methanol wash steps of the remaining DBS punches prior to SUAC derivatization reduced the presence of underivatized acylcarnitines, resulting in a 4-fold reduction of underivatized palmitoylcarnitine. Palmitoylcarnitine butyl ester is detected at m/z 456 while the underivatized species is detected at m/z 400, which is also the mass of dodecanoylcarnitine butyl ester. The linearity of the SUAC assay was unchanged by the additional wash steps. For butyl esterification methods, the preferred analytic procedure, the presence of AC can compromise the results of a newborn screen for the actual concentrations of acylcarnitines. It is essential to remove any underivatized acylcarnitines prior to SUAC analysis. Conclusion: The additional methanol wash steps did not alter SUAC assay results but did remove underivatized acylcarnitines which could result in the incorrect quantification of acylcarnitines. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
  • [41] Development and validation of an LC-MS/MS method for the analysis of ivermectin in plasma, whole blood, and dried blood spots using a fully automatic extraction system
    Duthaler, Urs
    Suenderhauf, Claudia
    Gaugler, Stefan
    Vetter, Beatrice
    Krahenbuhl, Stephan
    Hammann, Felix
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 172 : 18 - 25
  • [42] Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery
    Koster, Remco A.
    Alffenaar, Jan-Willem C.
    Greijdanus, Ben
    Uges, Donald R. A.
    TALANTA, 2013, 115 : 47 - 54
  • [43] Metabolite Profiles from Dried Biofluid Spots for Metabonomic Studies using UPLC Combined with oaToF-MS
    Michopoulos, Filippos
    Theodoridis, Georgios
    Smith, Christopher J.
    Wilson, Ian D.
    JOURNAL OF PROTEOME RESEARCH, 2010, 9 (06) : 3328 - 3334
  • [44] Development and validation of an enantioselective LC-MS/MS method for the analysis of the anthelmintic drug praziquantel and its main metabolite in human plasma, blood and dried blood spots
    Meister, Isabel
    Leonidova, Anna
    Kovac, Jana
    Duthaler, Urs
    Keiser, Jennifer
    Huwyler, Joerg
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 118 : 81 - 88
  • [45] Validation of amino-acids measurement in dried blood spot by FIA-MS/MS for PKU management (vol 49, pg 1047, 2016)
    Bruno, C.
    Dufour-Rainfray, D.
    Patin, F.
    Vourc'h, P.
    Guilloteau, D.
    Maillot, F.
    Labarthe, F.
    Tardieu, M.
    Andres, C. R.
    Emond, P.
    Blasco, H.
    CLINICAL BIOCHEMISTRY, 2017, 50 (09) : 546 - 546
  • [46] High resolution mass spectrometry newborn screening applications for quantitative analysis of amino acids and acylcarnitines from dried blood spots
    Pickens, C. Austin
    Petritis, Konstantinos
    ANALYTICA CHIMICA ACTA, 2020, 1120 : 85 - 96
  • [47] High resolution mass spectrometry newborn screening applications for quantitative analysis of amino acids and acylcarnitines from dried blood spots
    Pickens, C. Austin
    Petritis, Konstantinos
    Analytica Chimica Acta, 2020, 1120 : 85 - 96
  • [48] The use of automated electrospray ionization tandem MS for the diagnosis of inborn errors of metabolism from dried blood spots
    Johnson, AW
    Mills, K
    Clayton, PT
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (03) : 932 - 938
  • [49] Sensitive and Robust LC-MS/MS Assay to Quantify 25-Hydroxyvitamin D in Leftover Protein Extract from Dried Blood Spots
    Boelt, Sanne Grundvad
    Melgaard, Lars
    Thorbek, Marta Jadwiga
    MacSween, Nadia Sara Jensen
    McGrath, John J.
    Cohen, Arieh S.
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2021, 7 (04)
  • [50] Simultaneous determination of 17α-hydroxypregnenolone and 17α-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS
    Higashi, Tatsuya
    Nishio, Tadashi
    Uchida, Syouko
    Shimada, Kazutake
    Fukushi, Masaru
    Maeda, Masako
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 48 (01) : 177 - 182